The European Commission has published an analysis detailing the benefits of enacting the European Biotech Act, which was ...

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Now, she helps life sciences startups design, staff and run companies, including finding and hiring chief executives.

New K-NIBRT training hub addresses South Korea's critical biotech workforce shortage, graduating 3,400+ students in 2025 to ...

Natera gets a buy rating reaffirmed, driven by robust expansion plans, recent FDA approval, and upgraded FY26 revenue ...

Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash.

NTLA gains momentum after positive phase III data for its CRISPR therapy, while ADMA faces pricing and inventory pressure in IG markets.

Quinn Emanuel, with more than 1,300 lawyers world-wide, is known for high-profile cases including representing Harvard ...

The shares of Q-Line Biotech IPO are commanding a strong premium in the grey market. According to Investorgain, the GMP of ...

Domestic firms dominate China’s drug approvals amid jump in spending and out-licensing deals as regulator speeds path to ...

China’s biotech industry is only barely trailing — and in some areas, is already surpassing — America’s. China now initiates ...

A biotech firm with ties to the San Antonio area has closed on a major funding round.